Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDCC Regulatory News (DCC)

Share Price Information for DCC (DCC)

Share Price is delayed by 15 minutes
Get Live Data
5,975.00    -40.00 (-0.67%)
Bid:
5,990.00
Ask:
5,995.00
Spread: 5.00 (0.083%)
Market Cap: £5.10b
DCC Live PriceLast checked at - London Stock Exchange

Intraday DCC Share Chart

Man Group PLC : Form 8.3 - DCC Plc

Today 11:33

Man Group PLC : Form 8.3 - DCC Plc

Ap27

FORM 8.3

IRISH TAKEOVER PANEL

OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVERRULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

(a) Full name of discloserMan Group PLC
(b) Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. 
(c) Name of offeror/offeree in relation to whose relevant securities this form relates Use a separate form for each offeror/offereeDCC plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1) 
(e) Date position held/dealing undertaken For an opening position disclosure, state the latest practicable date prior to the disclosure05/06/2026
(f) In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”No

2. INTERESTS AND SHORT POSITIONS

If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.

Ap28

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)(Note 2)

Class of relevant security (Note 3)€0.25 Ordinary Shares
 InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled2,210,1022.59  
(2) Cash-settled derivatives414,730.000.4913,992.000.02
(3) Stock-settled derivatives (including options) and agreements to purchase/ sell    
Total2,624,8323.0713,992.000.02

All interests and all short positions should be disclosed.

Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevantsecurityPurchase/saleNumber ofsecuritiesPrice per unit(Note 5)

Ap29

(b) Cash-settled derivative transactions

Class ofrelevantsecurityProduct description e.g. CFDNature of dealinge.g. opening/ closing a long/ short position, increasing/ reducing a long/ short positionNumber ofreference securities (Note 6)Price per unit (Note 5)
€0.25 OrdinaryEquity SwapIncreasing a long position17160.2668 EUR

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relates (Note 6)Exerciseprice per unitType e.g. American, Europeanetc.Expiry dateOption moneypaid/ received per unit

(ii) Exercise

Class of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit (Note 5)

(d) Other dealings (including transactions in respect of new securities) (Note 3)

Class of relevant securityNature of dealing e.g. subscription, conversion, exerciseDetailsPrice per unit (if applicable) (Note 5)

Ap30

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer. Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
 None

(b) Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
 None

(c) Attachments

Is a Supplemental Form 8 attached?NO

Date of disclosure08/06/2026
Contact nameMolly Childs
Telephone number+442071443714

Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service.

Ap31

NOTES ON FORM 8.3

1. See the definition of “connected fund manager” in Rule 2.2 of Part A of the Rules.

2. See the definition of “interest in a relevant security” in Rule 2.5 of Part A of the Rules and see Rule 8.6(a) and (b) of Part B of the Rules.

3. See the definition of “relevant securities” in Rule 2.1 of Part A of the Rules.

4. See the definition of “dealing” in Rule 2.1 of Part A of the Rules.

5. If the economic exposure to changes in the price of securities is limited, for example, by virtue of a stop loss arrangement relating to a spread bet, full details must be given.

6. See Rule 2.5(d) of Part A of the Rules.

7. If details included in a disclosure under Rule 8 are incorrect, they should be corrected as soon as practicable in a subsequent disclosure. Such disclosure should state clearly that it corrects details disclosed previously, identify the disclosure or disclosures being corrected, and provide sufficient detail for the reader to understand the nature of the corrections. In the case of any doubt, the Panel should be consulted.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

References in these notes to “the Rules” are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.

Date   Source Headline
1st Jul 20257:00 amRNSTransaction in Own Shares
30th Jun 20257:00 amRNSTransaction in Own Shares
27th Jun 20257:00 amRNSTransaction in Own Shares
26th Jun 20257:00 amRNSTransaction in Own Shares
25th Jun 20257:00 amRNSTransaction in Own Shares
24th Jun 20257:00 amRNSTransaction in Own Shares
23rd Jun 20257:00 amRNSTransaction in Own Shares
20th Jun 20257:00 amRNSTransaction in Own Shares
19th Jun 20257:00 amRNSTransaction in Own Shares
18th Jun 20257:00 amRNSTransaction in Own Shares
17th Jun 20257:00 amRNSTransaction in Own Shares
16th Jun 20257:00 amRNSTransaction in Own Shares
13th Jun 20257:00 amRNSTransaction in Own Shares
12th Jun 20257:00 amRNSTransaction in Own Shares
11th Jun 20253:11 pmRNSHolding in Company TR-1
11th Jun 202510:00 amRNS2025 Annual Report, Notice of AGM and Proxy Form
11th Jun 20257:00 amRNSTransaction in Own Shares
10th Jun 20257:00 amRNSTransaction in Own Shares
9th Jun 20257:00 amRNSTransaction in Own Shares
6th Jun 20257:00 amRNSTransaction in Own Shares
5th Jun 20257:00 amRNSTransaction in Own Shares
4th Jun 20257:00 amRNSTransaction in Own Shares
3rd Jun 20257:00 amRNSTransaction in Own Shares
2nd Jun 20257:00 amRNSTransaction in Own Shares
30th May 20255:20 pmRNSTotal Voting Rights
30th May 20255:00 pmRNSDirector/PDMR Shareholding
30th May 20257:00 amRNSTransaction in Own Shares
29th May 20257:00 amRNSTransaction in Own Shares
28th May 20257:00 amRNSTransaction in Own Shares
27th May 20257:00 amRNSLaunch of £100 million Share Buyback Programme
23rd May 20255:10 pmRNSDirector/PDMR Shareholding
13th May 20257:00 amRNSResults for the year ended 31 March 2025
22nd Apr 20257:00 amRNSDisposal of DCC Healthcare
9th Apr 20257:00 amRNSDCC Leadership Changes
28th Feb 202511:00 amRNSTotal Voting Rights
5th Feb 20257:00 amRNSQ3 Trading Statement
9th Dec 202412:23 pmRNSDirector Declaration
29th Nov 20242:33 pmRNSTotal Voting Rights
18th Nov 20245:30 pmRNSDirector/PDMR Shareholding
12th Nov 20247:01 amRNSResults for the six months ended 30 September 2024
12th Nov 20247:00 amRNSStrategy Update: DCC to focus on Energy sector
20th Aug 20245:52 pmRNSHolding in Company TR-1
31st Jul 20242:20 pmRNSTotal Voting Rights
11th Jul 20244:53 pmRNSResult of AGM
11th Jul 20247:02 amRNSBoard Appointment
11th Jul 20247:01 amRNSDivestment of Hong Kong Energy Business
11th Jul 20247:00 amRNSAGM Trading Statement
12th Jun 202410:09 amRNS2024 Sustainability Report
12th Jun 202410:05 amRNS2024 Annual Report, Notice of AGM and Proxy Form
31st May 20245:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.